EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Role of chemokine receptor 2 in rheumatoid arthritis: A research update

Weile Chen, Yilong Fang, Huihui Wang, Xuewen Tan, Xiangling Zhu, Zhen Xu, Haifeng Jiang, Xuming Wu, Wenming Hong, Xinming Wang, Jiajie Tu, Wei Wei

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.109755 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Weile Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui C…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Receptors, CCR2. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a multisystemic and inflammatory autoimmune disease characterized by joint destruction. The C-C motif chemokine receptor 2 (CCR2) is mainly expressed in monocytes and T cells, initiating their migration to sites of inflammation, ultimately leading to cartilage damage and bone destruction. CCR2 has long been considered a prospective target for treating autoimmune diseases. However, clinical studies on inhibitors or neutralizing antibodies against CCR2 in RA have exhibited limited efficacy. Recent evidence indicates that CCR2 may play different roles in RA. Hence, a comprehensive understanding regarding the role of CCR2 may facilitate the development of targeted drugs and provide novel insights for improving CCL2-mediated inflammatory diseases. This review summarizes the biological characteristics of CCR2, the related signaling pathways, and recent developments in CCR2-targeting therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidReceptors, CCR2HumansChemokine CCL2InflammationMonocytes

Stichwörter der Autor:innen

CCL2CCR2Rheumatoid arthritisRheumatoid arthritis-related cellsTherapeutic target

Substanzen

Chemokine CCL2Receptors, CCR2

Autor:innen und Institutionen

  • Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicin…
  • The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Zitieren

APA

Chen, W., Fang, Y., Wang, H., Tan, X., Zhu, X., Xu, Z., Jiang, H., Wu, X., Hong, W., Wang, X., Tu, J., & Wei, W. (2023). Role of chemokine receptor 2 in rheumatoid arthritis: A research update. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.109755

Vancouver

Chen W, Fang Y, Wang H, Tan X, Zhu X, Xu Z, et al. Role of chemokine receptor 2 in rheumatoid arthritis: A research update. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.109755

BibTeX
@article{Chen2023,
  author = {Chen, Weile and Fang, Yilong and Wang, Huihui and Tan, Xuewen and Zhu, Xiangling and Xu, Zhen and Jiang, Haifeng and Wu, Xuming and Hong, Wenming and Wang, Xinming and Tu, Jiajie and Wei, Wei},
  title = {Role of chemokine receptor 2 in rheumatoid arthritis: A research update},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.109755}
}
Kostenlos starten →